Spironolactone Diuresis in Patients with Cirrhosis and Ascites
- 14 November 1970
- Vol. 4 (5732), 401-403
- https://doi.org/10.1136/bmj.4.5732.401
Abstract
Increased aldosterone levels with consequent or diuretic-potentiated electrolyte abnormalities are an important consideration when patients with cirrhosis and ascites undergo diuresis. A simple clinical method using the urinary Na/K ratio as a guide to spironolactone dosage is outlined. Patients with a ratio greater than 1 responded well to 100 mg. of spironolactone a day; those when it was one or less responded well to 200 to 1,000 mg. a day. Administration of spironolactone alone (11 patients) or as the main diuretic (three patients) was a safe and effective means of inducing sustained uncomplicated diuresis in all these patients.Keywords
This publication has 11 references indexed in Scilit:
- Electrolyte excretion during the spontaneous recovery from the ascitic phase of cirrhosis of the liverAmerican Journal Of Medicine, 1967
- COMPLICATIONS OF DIURETIC THERAPY IN HEPATIC CIRRHOSISThe Lancet, 1966
- The Use of Ethacrynic Acid in Patients with Cirrhosis and AscitesGastroenterology, 1965
- BODY AND SERUM POTASSIUM IN LIVER DISEASE .I. RELATIONSHIP TO HEPATIC FUNCTION AND ASSOCIATED FACTORS1965
- Significance of aldosterone antagonism in the treatment of edema and ascitesAmerican Journal Of Medicine, 1962
- THE METABOLISM OF ALDOSTERONE IN NORMAL SUBJECTS AND IN PATIENTS WITH HEPATIC CIRRHOSIS*JCI Insight, 1962
- HUMAN ASSAY OF ELECTROLYTE-ACTIVE STEROIDS AND THEIR ANTAGONISTS1962
- A Comparison of the Properties of Chlorothiazide, Spironolactone and a Combination of Both as Diuretic AgentsNew England Journal of Medicine, 1961
- EXCHANGEABLE POTASSIUM IN WASTING, AMYOTROPHY, HEART-DISEASE, AND CIRRHOSIS OF THE LIVERThe Lancet, 1961
- Sodium Diuresis Induced by Steroidal Antagonists of AldosteroneScience, 1957